(Q48963010)

17 February 2018

title

Oligomeric and fibrillar species of beta-amyloid (A beta 42) both impair mitochondrial function in P301L tau transgenic mice. (English)

1 reference

17 February 2018

author

Anne Eckert

1

1 reference

17 February 2018

Ulrich Brandt

7

1 reference

17 February 2018

Jürgen Götz

10

1 reference

17 February 2018

author name string

Susanne Hauptmann

2

1 reference

17 February 2018

Isabel Scherping

3

1 reference

17 February 2018

Jessica Meinhardt

4

1 reference

17 February 2018

Virginie Rhein

5

1 reference

17 February 2018

Stefan Dröse

6

1 reference

17 February 2018

Marcus Fändrich

8

1 reference

17 February 2018

Walter E Müller

9

1 reference

17 February 2018

publication date

16 August 2008

1 reference

17 February 2018

Journal of Molecular Medicine

published in

1 reference

17 February 2018

volume

86

1 reference

17 February 2018

page(s)

1255-1267

1 reference

17 February 2018

issue

11

1 reference

17 February 2018

https://scigraph.springernature.com/pub.10.1007/s00109-008-0391-6

exact match

0 references

cites work

The aggregation kinetics of Alzheimer's beta-amyloid peptide is controlled by stochastic nucleation

1 reference

12 December 2020

Globular amyloid beta-peptide oligomer - a homogenous and stable neuropathological protein in Alzheimer's disease

1 reference

12 December 2020

Glycosaminoglycans and beta-amyloid, prion and tau peptides in neurodegenerative diseases

1 reference

12 December 2020

Mitochondrial respiratory chain activity in the human brain as a function of age

1 reference

12 December 2020

The role of cell-derived oligomers of Abeta in Alzheimer's disease and avenues for therapeutic intervention.

1 reference

12 December 2020

Common structure and toxic function of amyloid oligomers implies a common mechanism of pathogenesis

1 reference

12 December 2020

Mitochondrial function in brain tissue in primary degenerative dementia.

1 reference

12 December 2020

Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases

1 reference

12 December 2020

Functional Genomics meets neurodegenerative disorders. Part II: application and data integration

1 reference

12 December 2020

FTIR reveals structural differences between native beta-sheet proteins and amyloid fibrils.

1 reference

12 December 2020

A quantitative study of the ultrastructure of pyramidal neurons of the cerebral cortex in Alzheimer's disease in relationship to the degree of dementia.

1 reference

12 December 2020

A decade of tau transgenic animal models and beyond

1 reference

12 December 2020

Mitochondrial Abeta: a potential focal point for neuronal metabolic dysfunction in Alzheimer's disease.

1 reference

12 December 2020

Soluble Beta-Amyloid Leads to Mitochondrial Defects in Amyloid Precursor Protein and Tau Transgenic Mice

1 reference

12 December 2020

Animal models of Alzheimer's disease and frontotemporal dementia

1 reference

12 December 2020

Alzheimer's disease is a synaptic failure

1 reference

12 December 2020

beta-Amyloid induces paired helical filament-like tau filaments in tissue culture

1 reference

12 December 2020

Surface plasmon resonance and nuclear magnetic resonance studies of ABAD-Abeta interaction

1 reference

12 December 2020

Staging of Alzheimer's disease-related neurofibrillary changes

1 reference

12 December 2020

Different conformations of amyloid beta induce neurotoxicity by distinct mechanisms in human cortical neurons.

1 reference

12 December 2020

Neuropathological stageing of Alzheimer-related changes

1 reference

12 December 2020

Differential effects of oligomeric and fibrillar amyloid-beta 1-42 on astrocyte-mediated inflammation.

1 reference

12 December 2020

In vitro characterization of conditions for amyloid-beta peptide oligomerization and fibrillogenesis

1 reference

12 December 2020

Transgenic animal models of Alzheimer's disease and related disorders: histopathology, behavior and therapy.

1 reference

12 December 2020

Protein aggregation and aggregate toxicity: new insights into protein folding, misfolding diseases and biological evolution

1 reference

12 December 2020

ABAD directly links Abeta to mitochondrial toxicity in Alzheimer's disease.

1 reference

12 December 2020

Proteomic and functional analyses reveal a mitochondrial dysfunction in P301L tau transgenic mice.

1 reference

12 December 2020

Directed selection of a conformational antibody domain that prevents mature amyloid fibril formation by stabilizing Abeta protofibrils

1 reference

12 December 2020

Amyloid beta-induced changes in nitric oxide production and mitochondrial activity lead to apoptosis

1 reference

12 December 2020

Association of missense and 5'-splice-site mutations in tau with the inherited dementia FTDP-17

1 reference

12 December 2020

Amyloid beta peptides act directly on single neurons

1 reference

12 December 2020

Mitochondrial dysfunction in sporadic and genetic Alzheimer's disease

1 reference

12 December 2020

Mitochondrial dysfunction: an early event in Alzheimer pathology accumulates with age in AD transgenic mice

1 reference

12 December 2020

Posttranslational modifications of tau--role in human tauopathies and modeling in transgenic animals

1 reference

12 December 2020

Tau filament formation in transgenic mice expressing P301L tau.

1 reference

12 December 2020

Impaired Cu/Zn-SOD activity contributes to increased oxidative damage in APP transgenic mice

1 reference

12 December 2020

Age-dependent impairment of mitochondrial function in primate brain.

1 reference

12 December 2020

Amyloid beta, mitochondrial dysfunction and synaptic damage: implications for cognitive decline in aging and Alzheimer's disease

1 reference

12 December 2020

Accelerated extinction of conditioned taste aversion in P301L tau transgenic mice.

1 reference

12 December 2020

Impaired spatial reference memory and increased exploratory behavior in P301L tau transgenic mice.

1 reference

12 December 2020

Alzheimer disease amyloid beta protein forms calcium channels in bilayer membranes: blockade by tromethamine and aluminum

1 reference

12 December 2020

Neurodegenerative tauopathies

1 reference

12 December 2020

Role for glyoxalase I in Alzheimer's disease.

1 reference

12 December 2020

Naturally secreted oligomers of amyloid beta protein potently inhibit hippocampal long-term potentiation in vivo

1 reference

12 December 2020

Association of ATP synthase alpha-chain with neurofibrillary degeneration in Alzheimer's disease

1 reference

12 December 2020

Triple-transgenic model of Alzheimer's disease with plaques and tangles: intracellular Abeta and synaptic dysfunction

1 reference

12 December 2020

Formation of neurofibrillary tangles in P301l tau transgenic mice induced by Abeta 42 fibrils

1 reference

12 December 2020

Tau phosphorylation and aggregation in Alzheimer's disease pathology

1 reference

12 December 2020

Phases of A beta-deposition in the human brain and its relevance for the development of AD.

1 reference

12 December 2020

Pronuclear injection for the production of transgenic mice

1 reference

12 December 2020

Selective loss of KGDHC-enriched neurons in Alzheimer temporal cortex: does mitochondrial variation contribute to selective vulnerability?

1 reference

12 December 2020

Abeta treatment and P301L tau expression in an Alzheimer's disease tissue culture model act synergistically to promote aberrant cell cycle re-entry

1 reference

12 December 2020

Overexpression of tau protein inhibits kinesin-dependent trafficking of vesicles, mitochondria, and endoplasmic reticulum: implications for Alzheimer's disease

1 reference

12 December 2020

Divergent phosphorylation pattern of tau in P301L tau transgenic mice.

1 reference

12 December 2020

Functional role of lipoprotein receptors in Alzheimer's disease

1 reference

12 December 2020

10.1007/S00109-008-0391-6

Identifiers

DOI

1 reference

17 February 2018

PubMed ID

18709343

1 reference

17 February 2018